Kiran Mazumdar-Shaw - Director, 10%+ Owner at Bicara Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
BCAX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kiran Mazumdar-Shaw since 07 Feb 2025

Holdings reported by Kiran Mazumdar-Shaw for Bicara Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,443,122 $58,842,042 $13.24 16 Sep 2024 By Biocon Limited
Common Stock 1,080,775 $14,313,136 $13.24 16 Sep 2024 By Biocon Pharma Inc.
Common Stock 432,736 $5,730,896 $13.24 16 Sep 2024 By Carica Investments
Common Stock 324,552 $4,298,172 $13.24 16 Sep 2024 By Glentech International
Stock Option (Right to Buy) 23,746 09 Jun 2025 Direct Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Biocon Limited Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Biocon Pharma Inc. Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Carica Investments Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Glentech International Common Stock

Transactions reported by Kiran Mazumdar-Shaw for Bicara Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.